UTMD-GLP-1

N/A

Report date: 2025/12/12 17:32:31

Base Information

Drug NameUTMD-GLP-1
Drug Alias NameGLP-1 gene therapy (Baylor Scott & White Research Institute)UTMD-GLP-1
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBaylor Scott & White Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesBaylor Scott & White Research Institute
Inactive CompaniesN/A
Active IndicationsHeart Failure
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A